geniposide has been researched along with Choroid Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, J; Li, L; Liu, X; Liu, Y; Qin, B; Qiu, Z; Sang, A; Zhou, Y; Zhu, M | 1 |
| Kim, BC; Koo, HJ; Lee, S; Lim, CJ; Park, EH; Shin, KH | 1 |
2 other study(ies) available for geniposide and Choroid Neovascularization
| Article | Year |
|---|---|
Geniposide alleviates choroidal neovascularization by downregulating HB-EGF release from RPE cells by downregulating the miR-145-5p/NF-κB axis.
Topics: Animals; Cells, Cultured; Choroidal Neovascularization; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Heparin-binding EGF-like Growth Factor; Iridoids; Male; Mice; MicroRNAs; Retinal Pigment Epithelium | 2021 |
Geniposide, an anti-angiogenic compound from the fruits of Gardenia jasminoides.
Topics: Angiogenesis Inhibitors; Animals; Chickens; Choroidal Neovascularization; Dose-Response Relationship, Drug; Fruit; Gardenia; Iridoids; Phytotherapy; Plant Extracts; Pyrans | 2004 |